Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How to do a mitral valvuloplasty

A Vahanian1

  • 1Cardiology Department, Tenon Hospital, Paris, France.

International Journal of Cardiology
|July 5, 1996
PubMed
Summary
This summary is machine-generated.

Percutaneous Mitral Commissurotomy (PMC) effectively treats mitral stenosis with low risk in high-volume centers, offering good mid-term results. Patient selection for this procedure is multifactorial, considering clinical and anatomical factors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiac CT-scan for mitral valve calcification assessment before percutaneous commissurotomy: the multicentre prospective CALCIMIT study.

European heart journal. Cardiovascular Imaging·2026
Same author

Predictors of mitral annulus enlargement? A real-time three-dimensional transesophageal study.

International journal of cardiology·2018
Same author

Identifying the needs for competency-based education in Europe: a needs assessment of cardiologists across 52 countries.

Journal of European CME·2018
Same author

Eclipsed mitral regurgitation: an unusual cause of acute heart failure.

European heart journal. Cardiovascular Imaging·2016
Same author

Mitral regurgitation. Timing of surgery or interventional treatment.

Herz·2015
Same author

Percutaneous aortic valve interventions in heart failure patients.

Minerva cardioangiologica·2015
Same journal

Applicability of ischemic heart disease clinical practice guidelines in low- and middle-income countries.

International journal of cardiology·2026
Same journal

Effectiveness of a new diagnostic algorithm for the diagnosis of unexplained syncope in patients with hypertrophic cardiomyopathy.

International journal of cardiology·2026
Same journal

The predictive role of the FIB-4 index in identifying arrhythmic risk among patients with nonischemic dilated cardiomyopathy.

International journal of cardiology·2026
Same journal

Beyond arrhythmias: Exploring heart failure in arrhythmogenic cardiomyopathy.

International journal of cardiology·2026
Same journal

Corrigendum to "First-in-human study of the K-Clip™ transcatheter annular repair system for severe functional tricuspid regurgitation" [International Journal of Cardiology 390(2023) / IJCA 131174].

International journal of cardiology·2026
Same journal

From evidence to practice: Identifying candidates for semaglutide in chronic atherosclerotic disease.

International journal of cardiology·2026
See all related articles

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Percutaneous Mitral Commissurotomy (PMC) has evolved significantly since its 1984 inception.
  • It is a widely adopted treatment for mitral stenosis.

Purpose of the Study:

  • To evaluate the effectiveness and outcomes of PMC.
  • To identify predictors of immediate and mid-term results.
  • To clarify the role of PMC in relation to surgical options.

Main Methods:

  • Review of patient data and procedural outcomes.
  • Analysis of factors influencing immediate and mid-term results.
  • Comparison of PMC with surgical interventions.

Main Results:

Related Experiment Videos

  • PMC is effective for a broad range of mitral stenosis patients.
  • Low risk is associated with high-volume centers.
  • Good mid-term results are achievable.
  • Predictors for immediate results include age, prior surgery, anatomy, and procedural factors.
  • Predictors for mid-term results include anatomy, NYHA class, cardiomegaly, and initial outcome quality.

    • Conclusions:

    • Candidate selection for PMC is multifactorial, relying on clinical and anatomical parameters.
    • PMC and surgical mitral valve repair/replacement are complementary, not competing, treatment options.